NewsRx

Search our medical news database

HIV/AIDS Therapy

Novel lipopeptide protease inhibitors reduce resistance risk

Published in AIDS Weekly, June 9th, 2003

A novel series of lipopeptide protease inhibitors reduce the chance of HIV resistance mutations.

According to a recent study from France, "the structure of new lipopeptides targeting the enzymic dimer interface have been rationally improved, resulting in dimerization inhibitors of the human immunodeficiency virus 1 protease (K-id = 5 nM for the best inhibitor)."

"The contribution of each amino acid in inhibitory 3-mer lipopeptides was analyzed, demonstrating that the C-terminal amino acid residue may preferably be replaced by thyroxine and thyronine," according to J. Dumond and coauthors at the University of Paris.

"The negative...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook